Characteristics of patients with type 2 diabetes by hospitalisation status following COVID-19 diagnosis
| Non-hospitalised n=301 (88.8%) | N | Hospitalised n=38 (11.2%) | N | P value | |
| Age (years) | 54.7±8.9 | 301 | 56.9±7.4 | 38 | 0.100 |
| Gender | |||||
| Male Female | 152 (50.5 %) 149 (49.5 %) | 301 | 16 (42.1%) 22 (57.9%) | 38 | 0.422 |
| Days on MSKD | 317.3±390.0 | 301 | 381.0±491.0 | 38 | 0.445 |
| HbA1c at enrolment (%) | 8.0±1.7 | 301 | 7.9±1.8 | 38 | 0.761 |
| Mean glucose (mg/dL), enrolment to COVID-19 onset | |||||
| Fasting All | 134.7±29.7 131.7±28.9 | 293 298 | 139.1±28.6 139.4±30.6 | 36 36 | 0.390 0.158 |
| Mean ketones (mmol/L), enrolment to COVID-19 onset | 0.64±0.4 | 301 | 0.52±0.3 | 38 | 0.016 |
| Weight (kg) | |||||
| Enrolment COVID-19 onset Per cent weight loss | 110.6±24.1 102.8±22.0 6.8±6.2 | 299 293 291 | 112.9±26.8 108.8±27.1 4.2±5.2 | 38 36 36 | 0.622 0.206 0.009 |
| BMI (kg/m2) | |||||
| Enrolment COVID-19 onset | 37.3±7.4 34.6±6.7 | 299 293 | 38.3±7.8 36.7±7.6 | 38 36 | 0.467 0.118 |
Table reports mean±SD or N (%). Welch t-tests with unequal variances were performed for continuous variables, and Χ2 tests were performed for categorical variables.
BMI, body mass index; HbA1c, Hemoglobin A1c; MSKD, medically supervised ketogenic diet.